BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35276128)

  • 1. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Joannes A; Morzadec C; Duclos M; Gutierrez FL; Chiforeanu DC; Le Naoures C; De Latour B; Rouzé S; Wollin L; Jouneau S; Vernhet L
    Toxicol Appl Pharmacol; 2022 Apr; 441():115972. PubMed ID: 35276128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
    Joannes A; Voisin T; Morzadec C; Letellier A; Gutierrez FL; Chiforeanu DC; Le Naoures C; Guillot S; De Latour BR; Rouze S; Jaillet M; Crestani B; Wollin L; Jouneau S; Vernhet L
    Pulm Pharmacol Ther; 2023 Dec; 83():102267. PubMed ID: 37972706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Voisin T; Joannes A; Morzadec C; Lagadic-Gossmann D; Naoures CL; De Latour BR; Rouze S; Jouneau S; Vernhet L
    J Nutr Biochem; 2024 Mar; 125():109558. PubMed ID: 38185349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2-like 2 (NFE2L2) protein and the Smad2/3 pathway.
    Zhong L; Hao H; Chen D; Hou Q; Zhu Z; He W; Sun S; Sun M; Li M; Fu X
    J Cell Physiol; 2019 Mar; 234(3):2606-2617. PubMed ID: 30317545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.
    Huang Y; Xie Y; Abel PW; Wei P; Plowman J; Toews ML; Strah H; Siddique A; Bailey KL; Tu Y
    Biochem Pharmacol; 2020 Oct; 180():114172. PubMed ID: 32712053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation.
    Lambers C; Roth M; Jaksch P; Muraközy G; Tamm M; Klepetko W; Ghanim B; Zhao F
    Sci Rep; 2018 Jan; 8(1):1087. PubMed ID: 29348469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis.
    Artaud-Macari E; Goven D; Brayer S; Hamimi A; Besnard V; Marchal-Somme J; Ali ZE; Crestani B; Kerdine-Römer S; Boutten A; Bonay M
    Antioxid Redox Signal; 2013 Jan; 18(1):66-79. PubMed ID: 22703534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation.
    Guo X; Adeyanju O; Olajuyin AM; Mandlem V; Sunil C; Adewumi J; Huang S; Tucker TA; Idell S; Qian G
    Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1190-C1200. PubMed ID: 37661917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
    Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
    Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
    Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
    Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
    Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts.
    Huang LS; Sudhadevi T; Fu P; Punathil-Kannan PK; Ebenezer DL; Ramchandran R; Putherickal V; Cheresh P; Zhou G; Ha AW; Harijith A; Kamp DW; Natarajan V
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine Receptor D1 Is Exempt from Transforming Growth Factor
    Gao AY; Diaz Espinosa AM; Nguyen BBN; Link PA; Meridew J; Jones DL; Gibbard DF; Tschumperlin DJ; Haak AJ
    J Pharmacol Exp Ther; 2023 Sep; 386(3):277-287. PubMed ID: 37024146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling.
    Epstein Shochet G; Brook E; Bardenstein-Wald B; Shitrit D
    Respir Res; 2020 Feb; 21(1):56. PubMed ID: 32070329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
    Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
    PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
    Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
    Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
    J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy and the unfolded protein response promote profibrotic effects of TGF-β
    Ghavami S; Yeganeh B; Zeki AA; Shojaei S; Kenyon NJ; Ott S; Samali A; Patterson J; Alizadeh J; Moghadam AR; Dixon IMC; Unruh H; Knight DA; Post M; Klonisch T; Halayko AJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L493-L504. PubMed ID: 29074489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.